.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
Covington
Daiichi Sankyo
US Army
US Department of Justice
Mallinckrodt
UBS
Chinese Patent Office
Federal Trade Commission

Generated: January 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0309342.4

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-002Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-002Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-002Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET
Horizon PharmaRAYOSprednisoneTABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo➤ Subscribe➤ SubscribeTREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG PREDNISONE TABLET
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist